Between pregnancy biological variability of first trimester markers of Down syndrome and the implications for screening in subsequent pregnancies: an issue revisited
- 3 September 2002
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 22 (10) , 874-876
- https://doi.org/10.1002/pd.430
Abstract
Objectives To assess the level of correlation of first trimester biochemical and biophysical markers of Down syndrome between different pregnancies in the same individual. To assess the impact that between pregnancy biological variability has on the likelihood that women who are at increased risk in a first pregnancy being also at increased risk in a subsequent pregnancy. Methods During a three period women attending the OSCAR clinic at Harold Wood Hospital have had the opportunity to have first trimester screening for Down syndrome and other aneuploidies using the maternal serum biochemical markers free β‐human chorionic gonadotrophin (hCG) and pregnancy associated plasma protein‐A (PAPP‐A) in conjunction with fetal nuchal translucency (NT) thickness and maternal age. Of the 11 1105 women undergoing such screening, the computer records were examined for women who had more than one pregnancy. The results from 1002 women with two normal singleton pregnancies were available for analysis. Marker correlations (as MoM) were established between the pregnancies and the proportion of women likely to be at increased risk in each pregnancy estimated, as was the likelihood of women being at increased risk in both pregnancies. Results For fetal NT there was no correlation between NT MoM in the first and second pregnancy (r = 0.0959, p > 0.10). For maternal serum free β‐hCG MoM a significant correlation was found (r = 0.3976, p < 0.001), as was also found for PAPP‐A MoM (r = 0.4371, p < 0.001). Conclusion The implication for such between pregnancy marker association is that women who have an increased risk of Down syndrome in one pregnancy are two or three times more likely to repeat this event in their next pregnancy. This information may be useful in counselling women when undergoing first trimester screening in a subsequent pregnancy. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 11 references indexed in Scilit:
- Between pregnancy biological variability of first trimester markers of Down syndrome: implications for screening in subsequent pregnanciesPrenatal Diagnosis, 2001
- One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimesterBJOG: An International Journal of Obstetrics and Gynaecology, 2000
- The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalitiesPrenatal Diagnosis, 2000
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- Maternal age‐ and gestation‐specific risk for trisomy 21Ultrasound in Obstetrics & Gynecology, 1999
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- Letter. Correct estimation of parameters for ultrasound nuchal translucency screeningPrenatal Diagnosis, 1998
- BETWEEN-PREGNANCY BIOLOGICAL VARIABILITY OF MATERNAL SERUM ALPHA- FETOPROTEIN AND FREE BETA hCG: IMPLICATIONS FOR DOWN SYNDROME SCREENING IN SUBSEQUENT PREGNANCIESPrenatal Diagnosis, 1997
- Maternal serum markers levels in consecutive pregnancies: A possible genetic predisposition to abnormal levelsAmerican Journal of Medical Genetics, 1996
- Maternal serum screening for Down's syndrome taking account of the result in a previous pregnancyPrenatal Diagnosis, 1994